在结核病与糖尿病接触时,人脉膜巨功能受损
Léanie Kleynhans1,2,3, Carine Kunsevi-Kilola1, Happy Tshivhula1
1DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, SA MRC Centre for TB Research, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Research square
|December 9, 2024
概括
2型糖尿病 (T2D) 由于肺免疫细胞功能障碍,使结核病 (TB) 风险恶化. T2D 损害了膜巨对 Mycobacterium 结核病的反应,增加了细菌生长和结核病的严重程度.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 2型糖尿病 (T2D) 是已知的结核病 (TB) 的风险因素.
- 关联T2D与增加结核病易感性的特定免疫机制尚未完全理解.
- 肺部免疫细胞,特别是巨细胞,在防治结核病方面发挥着至关重要的作用.
研究的目的:
- 研究T2D和结核病暴露的个体中肺免疫细胞功能障碍的作用.
- 为了比较T2D和非T2D个体在Mycobacterium结核病 (M.tb) 感染时的膜巨细胞 (HAMs) 和单细胞衍生巨细胞 (MDMs) 的功能.
主要方法:
- 从有或没有T2D的结核病暴露个体中分离出配对的HAM和MDM.
- 巨被M.tb感染,并评估了细菌生长,细胞因子生产 (TNF,IL-1RA,CSF2) 和细胞表面标记物表达 (CD32,M1-like).
- 分析了支气管膜洗液中中性粒细胞的数量.
- 研究了HAMs中的基因表达和DNA甲基化模式.
主要成果:
- 与对照组相比,T2D-HAMs表现出增加的M.tb增长和更高的TNF产生.
- 在T2D患者的支气管支气管洗中观察到较少的中性粒细胞,与M.tb生长相反相关.
- T2D-HAMs和MDMs显示CD32表达减少,而T2D患者的M1型MDMs较少.
- 在T2D-HAMs中,M.tb诱导的基因表达被延迟,对基因的上调调节负面调节中性粒细胞迁移.
- T2D-HAM DNA显示过甲基化,而与TNF信号相关的基因被低甲基化.
结论:
- 肺巨中的T2D相关的免疫功能障碍有助于增加结核病的易感性和严重性.
- 变化的巨细胞功能,减少中性粒细胞的存在,以及T2D中的表观遗传变化可能解释了结核病风险的增加.
相关概念视频
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pulmonary Tuberculosis II
211
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
Pulmonary Tuberculosis IV
133
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
133
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Pulmonary Tuberculosis III
303
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
303


